Andrew Phillips
2019
In 2019, Andrew Phillips earned a total compensation of $4.2M as Former President & Chief Executive Officer at C4 Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $260,000 |
|---|---|
| Option Awards | $3,377,316 |
| Salary | $520,000 |
| Other | $36,359 |
| Total | $4,193,675 |
Phillips received $3.4M in option awards, accounting for 81% of the total pay in 2019.
Phillips also received $260K in non-equity incentive plan, $520K in salary and $36.4K in other compensation.
Rankings
In 2019, Andrew Phillips' compensation ranked 2,812th out of 13,971 executives tracked by ExecPay. In other words, Phillips earned more than 79.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,812 out of 13,971 | 80th |
Division Manufacturing | 1,017 out of 5,701 | 82nd |
Major group Chemicals And Allied Products | 337 out of 2,200 | 85th |
Industry group Drugs | 274 out of 1,886 | 86th |
Industry Biological Products, Except Diagnostic Substances | 66 out of 389 | 83rd |
Source: SEC filing on April 26, 2021.
Phillips' colleagues
We found two more compensation records of executives who worked with Andrew Phillips at C4 Therapeutics in 2019.